Daemen MJ - Search Results

1

Atherosclerotic Plaque Destabilization in Mice: A Comparative Study.

Hartwig H, Silvestre-Roig C, Hendrikse J, Beckers L, Paulin N, Van der Heiden K, Braster Q, Drechsler M, Daemen MJ, Lutgens E, Soehnlein O. Hartwig H, et al. Among authors: daemen mj. PLoS One. 2015 Oct 22;10(10):e0141019. doi: 10.1371/journal.pone.0141019. eCollection 2015. PLoS One. 2015. PMID: 26492161 Free PMC article.

2

Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage.

Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, Wellens H, de Muinck ED. Lutgens E, et al. Circulation. 1999 Jan 19;99(2):276-83. doi: 10.1161/01.cir.99.2.276. Circulation. 1999. PMID: 9892595

3

Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques.

Lutgens E, de Muinck ED, Kitslaar PJ, Tordoir JH, Wellens HJ, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Cardiovasc Res. 1999 Feb;41(2):473-9. doi: 10.1016/s0008-6363(98)00311-3. Cardiovasc Res. 1999. PMID: 10341847

4

Chronic myocardial infarction in the mouse: cardiac structural and functional changes.

Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. Lutgens E, et al. Among authors: daemen mj. Cardiovasc Res. 1999 Mar;41(3):586-93. doi: 10.1016/s0008-6363(98)00216-8. Cardiovasc Res. 1999. PMID: 10435030

5

Requirement for CD154 in the progression of atherosclerosis.

Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA. Lutgens E, et al. Among authors: daemen mj. Nat Med. 1999 Nov;5(11):1313-6. doi: 10.1038/15271. Nat Med. 1999. PMID: 10546000

6

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.

Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7464-9. doi: 10.1073/pnas.97.13.7464. Proc Natl Acad Sci U S A. 2000. PMID: 10861013 Free PMC article.

7

The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.

Kliffen M, Lutgens E, Daemen MJ, de Muinck ED, Mooy CM, de Jong PT. Kliffen M, et al. Among authors: daemen mj. Br J Ophthalmol. 2000 Dec;84(12):1415-9. doi: 10.1136/bjo.84.12.1415. Br J Ophthalmol. 2000. PMID: 11090485 Free PMC article.

8

Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice.

Lutgens E, de Muinck ED, Heeneman S, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1359-65. doi: 10.1161/hq0801.093669. Arterioscler Thromb Vasc Biol. 2001. PMID: 11498466

9

Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice.

Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF. Blankesteijn WM, et al. Among authors: daemen mj. Acta Physiol Scand. 2001 Sep;173(1):75-82. doi: 10.1046/j.1365-201X.2001.00887.x. Acta Physiol Scand. 2001. PMID: 11678729 Review.

10

Transforming growth factor-beta: a local or systemic mediator of plaque stability?

Lutgens E, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Circ Res. 2001 Nov 9;89(10):853-5. Circ Res. 2001. PMID: 11701610 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters